2000
A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates
Landry M, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew W, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C, Group T. A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates. Antimicrobial Agents And Chemotherapy 2000, 44: 688-692. PMID: 10681339, PMCID: PMC89747, DOI: 10.1128/aac.44.3.688-692.2000.Peer-Reviewed Original Research
1993
Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease
Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. Journal Of Clinical Microbiology 1993, 31: 2851-2856. PMID: 8263166, PMCID: PMC266143, DOI: 10.1128/jcm.31.11.2851-2856.1993.Peer-Reviewed Original ResearchConceptsCMV antigenemiaCentrifugation cultureClinical diseaseCMV antigensBlood samplesConventional cultureDetection of cytomegalovirusQuantitative cytomegalovirus antigenemiaHuman immunodeficiency virus-infected patientsBone marrow transplant recipientsCMV antigenemia testHigh-level antigenemiaVirus-infected patientsMarrow transplant recipientsDetection of antigenemiaCulture methodUse of immunofluorescenceAntigenemia testTransplant recipientsCMV infectionCytomegalovirus antigenemiaAntigenemiaIndividual patientsImmunoperoxidase stainingRapid diagnosis